- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03974529
Intensive Running Exercise Improves Parkinson's Motor and Non-motor Symptoms
High quality clinical trial and meta-analysis have demonstrated short term, and to a lesser extent, long term benefits in various outcome measures. To achieve positive effects, supervised progressive strength and aerobic endurance training program of 12 weeks was required. Extended progressive strength training improved muscle strength for up to 24 months. While aerobic endurance training would increase walking capacity up to 16 months. 1 There are data suggesting a threshold of intensity of exercise to be reached for the positive effect. This overall body of evidence suggests that regular vigorous exercise should be accorded a central place in the treatment of Parkinson's disease.
However, there was no evidence about regular intensive exercise of running in Parkinson's disease. And most of the studies were not randomized with a control group.
In this study, the investigators are to investigate the effect of regular vigorous aerobic exercise training of running on motor and non-motor symptoms, and quality-of-life of people with Parkinson's disease.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is growing volume of evidences support the positive effect of exercise and physical therapy to Parkinson's disease. Various exercise types have shown different positive effects. Gait training for 4 weeks showed a moderate improvement in balancing while balance training of 8 to 26 weeks decreased fall rate. Cued exercise would mildly increase the speed of the gait. Complementary exercises, such as Tai Chi and dancing, have shown improvement in balancing of the patients.
One of the main complaints of Parkinson's disease is rigidity. It is because of the musculoskeletal impairments which compromise the flexibility and stability of both axial structure (spine) and the extremities. Truncal stiffness and rigidity results in a stooped posture, which further undermines one's balance and agility. Flexibility training (stretching) is shown to be beneficial to all stages of patients with Parkinson's disease, in terms of improved both range of movement in joints and spinal stability. It is recommended that regular stretching should be the first step in one's exercise program to combat the muscle rigidity. High quality clinical trial and meta-analysis have demonstrated short term, and to a lesser extent, long term benefits in various outcome measures. To achieve positive effects, supervised progressive strength and aerobic endurance training program of 12 weeks was required. Extended progressive strength training improved muscle strength for up to 24 months. While aerobic endurance training would increase walking capacity up to 16 months.
There are data suggested a threshold of intensity of exercise to be reached for the positive effect. This overall body of evidence suggests that regular vigorous exercise should be accorded a central place in the treatment of Parkinson's disease.
In this study, the investigators are to investigate the effect of regular vigorous aerobic exercise training of running on motor and non-motor symptoms, and quality-of-life of people with Parkinson's disease.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- The Chinese University of Hong Kong
-
Contact:
- Danny TM Chan, MBChB FRCS
- Phone Number: 85235052624
- Email: tmdanny@surgery.cuhk.edu.hk
-
Contact:
- Margret Mak, PhD MAppSc
- Phone Number: 85227666708
- Email: margret.mak@polyu.edu.hk
-
Sub-Investigator:
- Margret Mak, PhD MAppSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient with idiopathic Parkinson's disease, aging from 40 years to 60 years old.
- Patient who are able to walk independently without walking aids for a distance of 30 meters.
Exclusion Criteria:
- Previous history of other neuro-degenerative diseases
- Presence of ischemic heart disease or musculoskeletal and cardiopulmonary diseases
- Presence of physical disability
- History of regular running practice in the past 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intensive running arm
20 patients will be assigned randomly to intensive running arm (intervention arm).
They will be required to complete a designed training protocol.
|
The patients who are assigned to this group will be required to finish a 90 minutes of training protocol, containing 30 minutes' warm-up stretching, and 60 minutes of supervised progressive aerobic endurance track running.
The training takes place two time per week, for 24 weeks.
|
|
Active Comparator: Physiotherapy arm
10 patients will be assigned randomly to physiotherapy arm.
They will be required to complete a designed training protocol.
|
The patients who are assigned to this group will be required to finish a 60 minutes of physiotherapy session.
The training takes place once per week, for 24 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unified Parkinson's disease rating scale Overall Score
Time Frame: Six months after finishing the training
|
A comprehensive 50 question assessment of both motor and non-motor symptoms associated with Parkinson's. The MDS-UPDRS features sections that require independent completion by people affected by Parkinson's and their carers, and sections to be completed by the clinician. Part 1: non-motor experiences of daily living Part 2: motor experiences of daily living Part 3: motor examination Part 4: motor complications. Some sections of the UPDRS scale require multiple grades assigned to each extremity with a possible maximum of 199 points. A score of 199 on the UPDRS scale represents the worst (total disability) with a score of zero representing (no disability). |
Six months after finishing the training
|
|
Parkinson's Disease Questionnaire - 39 (PDQ39) Quality of Life Score
Time Frame: Six months after finishing the training
|
The PDQ39 is a 39-item self-reporting questionnaire which assess the Parkinson's disease associated health related quality over the last month. PDQ-39 There are 39 questions in the long form Parkinson's Disease Questionnaire, with 8 discrete scales: mobility (10 items) activities of daily living (6 items) emotional well-being (6 items) stigma (4 items) social support (3 items) cognitions (4 items) communication (3 items) bodily discomfort (3 items) Patients are asked to think about their health and general well-being and to consider how often in the last month they have experienced certain events (e.g. difficulty walking 100 yards). Patients are asked to indicate the frequency of each event by selecting one of 5 options (likert Scale): never/occasionally/sometimes/often/always or cannot do at all. |
Six months after finishing the training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endurance
Time Frame: Six months after finishing the trainingBaseline, one month after finishing the training, and six months after finishing the training
|
The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes.
It is suitable in assessing endurance in patients with Parkinson's disease
|
Six months after finishing the trainingBaseline, one month after finishing the training, and six months after finishing the training
|
|
Gait performance
Time Frame: Six months after finishing the training
|
Fastest walking speed: Duration for individual walks without assistance for 10 meters
|
Six months after finishing the training
|
|
MiniBest Test Score
Time Frame: Six months after finishing the training
|
MiniBest test is an evaluation system focusing on the balance of patients with Parkinson's disease.
The maximum score for the system is 28 whereas the minimum score is 0. The higher the score is, the better the patient's function.
|
Six months after finishing the training
|
|
Mood
Time Frame: Six months after finishing the training
|
Symptoms related to anxiety and depression measured with Anxiety and depression Hospital Anxiety and Depression Scale (HADS).
It is a commonly used tools in hospital settings to determine the level of depression and anxiety.
There are 14 questions in total, with 7 items assessing level of depression whereas 7 for the level of anxiety.
Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.
The higher the score, the higher level of depression/ anxiety patient is experiencing.The HADS uses a scale and therefore the data returned from the HADS is ordinal.
|
Six months after finishing the training
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Danny TM Chan, Dr., Chinese University of Hong Kong
Publications and helpful links
Helpful Links
- Key Citation PARKINSON ' S DISEASE A Comprehensive Approach to Exercise
- Key Citation: Parkinson's disease: fitness counts
- Key Citation: American College of Sports Medicine. Cardiorespiratory exercise prescription. In: Ehrman JK, editor. , editor. ACSM's Guidelines for Exercise Testing and Prescription, 6th ed Baltimore: Lippincott Williams & Wilkins; 2010:448-462
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Run for PD -v1
- NTEC-2018-0330 (Registry Identifier: Joint CUHK-NTEC Clinical Research Ethics Committee (CREC))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Intensive running
-
CommonSpirit HealthUniversity of Colorado, Colorado SpringsWithdrawnExercise | Blood Pressure | Body Temperature Changes
-
Shanghai University of SportNot yet recruitingSport ParticipationChina
-
University of California, DavisRecruitingScarringUnited States
-
University of British ColumbiaCompleted
-
University of HaifaCompleted
-
University of FloridaCompleted
-
Rahmaningsih Mara SabirinIndonesia Endowment Fund for Education (LPDP), Ministry of Finance Republik...Active, not recruiting
-
University of the Balearic IslandsCompleted
-
National Taiwan Normal UniversityRecruitingEnergy Expenditure | Metabolic RegulationTaiwan
-
Luxembourg Institute of HealthDECATHLON SACompletedRunning-Related Injury (First-time)Luxembourg